v3.25.2
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of stock-based compensation expense
        
   2025   2024 
Cost of Goods Sold  $154,559   $93,713 
Selling, General and Administrative Expenses   1,457,547    866,071 
Stock Based Compensation Expense  $1,612,106   $959,784 
Schedule of fair value of option assumptions
        
   Year Ended 
   June 30, 2025   June 30, 2024 
Assumptions:          
Option life   6.25 years    6.25 years 
Risk-free interest rate   4.02-4.52%    4.35-4.47% 
Weighted average stock volatility   98.12%    99.4% 
Dividend yield   0.0%    0.0% 
Weighted average fair value of grants  $3.84   $4.69 
Schedule of stock option activity
           
   Options Outstanding 
   Number of
Shares
   Weighted
Average
Exercise Price
   Weighted
Average
Contractual
Life
            
Outstanding at June 30, 2023   1,127,140   $4.54   6.88 years
Grants   285,257    5.76    
Exercised   (10,332)   2.70    
Cancellations   (44,330)   4.18    
Outstanding at June 30, 2024   1,357,735   $4.72   6.60 years
Grants   520,000    4.78    
Exercised   (129,329)   2.79    
Cancellations   (84,664)   5.34    
Outstanding at June 30, 2025   1,623,576   $4.85   7.15 years